Risk factors for melanoma development
暂无分享,去创建一个
[1] T. Spector,et al. Pigmentation and Vitamin D Metabolism in Caucasians: Low Vitamin D Serum Levels in Fair Skin Types in the UK , 2009, PloS one.
[2] J. Malvehy,et al. Genome-wide association study identifies three loci associated with melanoma risk , 2009, Nature Genetics.
[3] T. Spector,et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi , 2009, Nature Genetics.
[4] K. Pienta. Critical appraisal of prostate-specific antigen in prostate cancer screening: 20 years later. , 2009, Urology.
[5] Tim K. Lee,et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls , 2009, International journal of epidemiology.
[6] R. Souchon,et al. Actual management of ductal carcinoma in situ of the breast , 2009, Archives of Gynecology and Obstetrics.
[7] Andreas Ziegler,et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes , 2009, International journal of cancer.
[8] N. Hayward,et al. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas , 2008, Melanoma research.
[9] S. Steinberg,et al. Corrigendum: ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma , 2008, Nature Genetics.
[10] Sabine Siesling,et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. , 2008, European journal of cancer.
[11] P. Pharoah. Shedding light on skin cancer , 2008, Nature Genetics.
[12] Kari Stefansson,et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma , 2008, Nature Genetics.
[13] R. Kirsner,et al. Melanoma in Hispanic and black Americans. , 2008, Cancer control : journal of the Moffitt Cancer Center.
[14] Nils Homer,et al. Common sequence variants on 20q11.22 confer melanoma susceptibility , 2008, Nature Genetics.
[15] F. Sera,et al. MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.
[16] V. Siskind,et al. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[17] M. Pollán,et al. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women , 2008, The British journal of dermatology.
[18] F. Langmark,et al. Population‐based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas , 2008, Genes, chromosomes & cancer.
[19] G. Botti,et al. Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma , 2007, The British journal of dermatology.
[20] M. Janssen-Heijnen,et al. Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] J. N. Newton Bishop,et al. Genetics: what advice for patients who present with a family history of melanoma? , 2007, Seminars in oncology.
[22] M. Ringnér,et al. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH , 2007, Oncogene.
[23] T. Spector,et al. Nevus Size and Number Are Associated with Telomere Length and Represent Potential Markers of a Decreased Senescence In vivo , 2007, Cancer Epidemiology Biomarkers & Prevention.
[24] J. Aitken,et al. Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme , 2007, Journal of medical screening.
[25] S. Puig,et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents , 2006, Journal of Medical Genetics.
[26] D. Pinkel,et al. MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma , 2006, Science.
[27] S. Ariyan,et al. Gender-Related Differences in Outcome for Melanoma Patients , 2006, Annals of surgery.
[28] Arjun Chanmugam,et al. Cutaneous malignant melanoma. , 2006, Mayo Clinic proceedings.
[29] J. Aitken,et al. Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002 , 2006, Cancer Causes & Control.
[30] P. Autier. Cutaneous malignant melanoma: facts about sunbeds and sunscreen , 2005, Expert review of anticancer therapy.
[31] C. Garbe,et al. Interventional study in 1,232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behavior , 2005, International journal of cancer.
[32] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. , 2005, European journal of cancer.
[33] J. Coebergh,et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. , 2005, European journal of cancer.
[34] Lisa M. Schwartz,et al. Skin biopsy rates and incidence of melanoma: population based ecological study , 2005, BMJ : British Medical Journal.
[35] J. Fridlyand,et al. RESPONSE: Re: Determinants of BRAF Mutations in Primary Melanomas , 2005 .
[36] M. Purdue. Re: Determinants of BRAF mutations in primary melanomas. , 2005, Journal of the National Cancer Institute.
[37] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.
[38] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. , 2005, European journal of cancer.
[39] E. de Vries,et al. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe. , 2004, European journal of cancer.
[40] B. Karlan,et al. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] E. Holly,et al. Incidence of cutaneous melanoma among non-Hispanic Whites, Hispanics, Asians, and Blacks: an analysis of California Cancer Registry data, 1988-93 , 1997, Cancer Causes & Control.
[42] Ajay N. Jain,et al. Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.
[43] V. Bataille,et al. Genetic epidemiology of melanoma. , 2003, European journal of cancer.
[44] N. Hayward,et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.
[45] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[46] Florence Demenais,et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. , 2002, Journal of the National Cancer Institute.
[47] R. Willemze,et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. , 2001, The Journal of investigative dermatology.
[48] J. Barrett,et al. Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. , 2001, The Journal of investigative dermatology.
[49] R. MacKie,et al. Development of melanocytic nevi in the first three years of life. , 2000, Journal of the National Cancer Institute.
[50] Lisa M. Schwartz,et al. Are increasing 5-year survival rates evidence of success against cancer? , 2000, JAMA.
[51] P Sasieni,et al. Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. , 2000, Journal of the National Cancer Institute.
[52] J Cuzick,et al. Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi , 1998, International journal of cancer.
[53] J. Cuzick,et al. The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. , 1998, British Journal of Cancer.
[54] D. Easton,et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies , 1995 .
[55] M. Skolnick,et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus , 1994, Nature Genetics.
[56] D. Bishop,et al. Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype , 1994, Melanoma research.
[57] P. Hersey,et al. An analysis of a melanoma epidemic , 1993, International journal of cancer.